EOMES and neoplasm: Checkpoint molecules, including inhibitory cell surface receptors and intracellular regulatory molecules, mediate tumor‐associated NK cell dysfunction,[11, 13] a status characterized by diminished effector functions, as well as by downregulation of the key transcription factors T‐bet and Eomes.[14] Therefore, checkpoint molecules represent potential targets for improving NK cell antitumor immunity.